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We present a deep convolutional neural network for breast cancer
screening exam classification, trained and evaluated on over 200,000
exams (over 1,000,000 images). Our network achieves an AUC of
0.895 in predicting whether there is a cancer in the breast, when
tested on the screening population. We attribute the high accuracy
of our model to a two-stage training procedure, which allows us to
use a very high-capacity patch-level network to learn from pixel-level
labels alongside a network learning from macroscopic breast-level
labels. To validate our model, we conducted a reader study with 14
readers, each reading 720 screening mammogram exams, and find
our model to be as accurate as experienced radiologists when pre-
sented with the same data. Finally, we show that a hybrid model,
averaging probability of malignancy predicted by a radiologist with a
prediction of our neural network, is more accurate than either of the
two separately. To better understand our results, we conduct a thor-
ough analysis of our network’s performance on different subpopula-
tions of the screening population, model design, training procedure,
errors, and properties of its internal representations.
deep learning | deep convolutional neural networks | breast cancer
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Breast cancer is the second leading cancer-related cause ofdeath among women in the US. In 2014, over 39 million
screening and diagnostic mammography exams were performed
in the US. It is estimated that in 2015 232,000 women were
diagnosed with breast cancer and approximately 40,000 died
from it (1). Although mammography is the only imaging
test that has reduced breast cancer mortality (2–4), there has
been discussion regarding the potential harms of screening,
including false positive recalls and associated false positive
biopsies. The vast majority of the 10–15% of women asked to
return following an inconclusive screening mammogram un-
dergo another mammogram and/or ultrasound for clarification.
After the additional imaging exams, many of these findings
are determined as benign and only 10–20% are recommended
to undergo a needle biopsy for further work-up. Among these,
only 20–40% yield a diagnosis of cancer (5). Evidently, there
is an unmet need to shift the balance of routine breast cancer
screening towards more benefit and less harm.
Traditional computer-aided detection (CAD) in mammog-
raphy is routinely used by radiologists to assist with image
interpretation, despite multicenter studies showing these CAD
programs do not improve their diagnostic performance (6).
These CAD programs typically use handcrafted features to
mark sites on a mammogram that appear distinct from normal
tissue structures. The radiologist decides whether to recall
these findings, determining clinical significance and actionabil-
ity. Recent developments in deep learning (7)—in particular,
deep convolutional neural networks (CNNs) (8–12)—open pos-
sibilities for creating a new generation of CAD-like tools.
This paper makes several contributions. Primarily, we train
and evaluate a set of strong neural networks on a mammogra-
phy dataset, with biopsy-proven labels, that is of a massive
size by the standards of medical image analysis, let alone
breast cancer screening. We use two complimentary types
of labels: breast-level labels indicating whether there is a
benign or malignant finding in each breast, and pixel-level
labels indicating the location of biopsied malignant and be-
nign findings. To quantify the value of pixel-level labels, we
compare a model using only breast-level labels against a model
using both breast-level and pixel-level labels. Our best model,
trained on both breast-level and pixel-level labels, achieves
an AUC of 0.895 in identifying malignant cases and 0.756 in
identifying benign cases on a non-enriched test set reflecting
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the screening population.
In the reader study, we compared the performance of our
best model to that of radiologists and found our model to
be as accurate as radiologists both in terms of area under
ROC curve (AUC) and area under precision-recall curve
(PRAUC). We also found that a hybrid model, taking the
average of the probabilities of malignancy predicted by a ra-
diologist and by our neural network, yields more accurate
predictions than either of the two separately. This suggests
that our network and radiologists learned different aspects
of the task and that our model could be effective as a tool
providing radiologists a second reader. Finally, we have
made the code and weights of our best models available at
https://github.com/nyukat/breast_cancer_classifier. With
this contribution, research groups that are working on improv-
ing screening mammography, which may not have access to a
large training dataset like ours, will be able to directly use our
model in their research or to use our pretrained weights as an
initialization to train models with less data. By making our
models public, we invite other groups to validate our results
and test their robustness to shifts in the data distribution.
Data
Our retrospective study was approved by our institutional
review board and was compliant with the Health Insurance
Portability and Accountability Act. Informed consent was
waived. This dataset∗ is a larger and more carefully curated
version of a dataset used in our earlier work (14, 15). The
dataset includes 229,426 digital screening mammography ex-
ams (1,001,093 images) from 141,473 patients. Each exam
contains at least four images,† corresponding to the four stan-
dard views used in screening mammography: R-CC (right
craniocaudal), L-CC (left craniocaudal), R-MLO (right medio-
lateral oblique) and L-MLO (left mediolateral oblique). A few
examples of exams are shown in Figure 1.
To extract labels indicating whether each breast of the
patient was found to have malignant or benign findings at the
end of the diagnostic pipeline, we relied on pathology reports
from biopsies. We have 5,832 exams with at least one biopsy
performed within 120 days of the screening mammogram.
Among these, biopsies confirmed malignant findings for 985
(8.4%) breasts and benign findings for 5,556 (47.6%) breasts.
234 (2.0%) breasts had both malignant and benign findings.
For the remaining screening exams that were not matched
with a biopsy, we assigned labels corresponding to the absence
of malignant and benign findings in both breasts.
For all exams matched with biopsies, we asked a group
of radiologists (provided with the corresponding pathology
reports) to retrospectively indicate the location of the biopsied
lesions at a pixel level. An example of such a segmentation is
shown in Figure 2. We found that, according to the radiolo-
gists, approximately 32.8% of exams were mammographically
occult, i.e., the lesions that were biopsied were not visible on
mammography, even retrospectively, and were identified using
other imaging modalities: ultrasound or MRI.
∗Details of its statistics and how it was extracted can be found in a separate technical report (13).
†Some exams contain more than one image per view as technologists may need to repeat an image
or provide a supplemental view to completely image the breast in a screening examination.
R-CC L-CC R-MLO L-MLO
Fig. 1. Examples of breast cancer screening exams. First row: both breasts without
any findings; second row: left breast with no findings and right breast with a malignant
finding; third row: left breast with a benign finding and right breast with no findings.
Fig. 2. An example of a segmenta-
tion performed by a radiologist. Left:
the original image. Right: the image
with lesions requiring a biopsy high-
lighted. The malignant finding is high-
lighted with red and benign finding with
green.
R-CC L-CC R-MLO L-MLO
CNN
malignant /
not malignant
left breast
benign /
not benign
right breast
benign /
not benign
left breast
malignant /
not malignant
right breast
Fig. 3. A schematic representation of how
we formulated breast cancer exam classifi-
cation as a learning task.
Deep CNNs for cancer classification
Problem definition. For each breast, we assign two binary la-
bels: the absence/presence of malignant findings in a breast,
and the absence/presence of benign findings in a breast. With
left and right breasts, each exam has a total of four binary
labels. Our goal is to produce four predictions corresponding
to the four labels for each exam. As input, we take four high-
resolution images corresponding to the four standard screening
mammography views. We crop each image to a fixed size of
2677 × 1942 pixels for CC views and 2974 × 1748 pixels for
MLO views. See Figure 3 for a schematic representation.
Model architecture. We trained a deep multi-view CNN of ar-
chitecture shown in Figure 4, inspired by (14). The overall
network consists of two core modules: (i) four view-specific
columns, each based on the ResNet architecture (11) that
outputs a fixed-dimension hidden representation for each mam-
mography view, and (ii) two fully connected layers to map
from the computed hidden representations to the output pre-
dictions. We used four ResNet-22‡ columns to compute a
‡ResNet-22 refers to our version of a 22-layer ResNet, with additional modifications such as a larger
kernel in the first convolutional layer. Details can be found in the SI.
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256-dimension hidden representation vector of each view. The
columns applied to L-CC/R-CC views share their weights. The
columns applied to L-MLO/R-MLO views share their weights
too. We concatenate the L-CC and R-CC representations
into a 512-dimension vector, and apply two fully connected
layers to generate predictions for the four outputs. We do
the same for the L-MLO and R-MLO views. We average the
probabilities predicted by the CC and MLO branches of the
model to obtain our final predictions.
R-MLOL-MLOR-CCL-CC
malignant /
not malignant
benign /
not benign
left breast
ResNet-22 ResNet-22
average average average average
average 
pooling
average 
pooling
average 
pooling
average 
pooling
concatenationconcatenation
fully connected layerfully connected layer
softmax softmax softmax softmax softmax softmax softmax softmax
ResNet-22 ResNet-22
malignant /
not malignant
benign /
not benign
left breast right breast right breast
Fig. 4. Architecture of our model. Four ResNet-22 columns
take the four views as input. The architecture is divided into
CC and MLO branches. In each branch, the corresponding
left and right representations from the ResNets are individu-
ally average-pooled spatially and concatenated, and two fully
connected layers are applied to compute the predictions for
the four outputs. The predictions are averaged between the
CC and MLO branches. Weights are shared between L-CC/R-
CC columns and L-MLO/R-MLO columns. When heatmaps
are added as additional channels to corresponding inputs, the
first layers of the columns are modified accordingly.
Fig. 5. The original
image, the ‘malig-
nant‘ heatmap over
the image and the
‘benign‘ heatmap
over the image.
Auxiliary patch-level classification model and heatmaps. The high
resolution of the images and the limited memory of modern
GPUs constrain us to use relatively shallow ResNets within our
model when using full-resolution images as inputs. To further
take advantage of the fine-grained detail in mammograms, we
trained an auxiliary model to classify 256× 256-pixel patches
of mammograms, predicting two labels: the presence or ab-
sence of malignant and benign findings in a given patch. The
labels for these patches are produced based on the pixel-level
segmentations of the corresponding mammograms produced
by clinicians. We refer to this model as a patch-level model,
in contrast to the breast-level model described in the section
above which operates on images of the whole breast.
Subsequently, we apply this auxiliary network to the full
resolution mammograms in a sliding window fashion to create
two heatmaps for each image (an example in Figure 5), one
containing an estimated probability of a malignant finding for
each pixel, and the other containing an estimated probability
of a benign finding. These patch classification heatmaps can
be used as additional input channels to the breast-level model
to provide supplementary fine-grained information.
Using separate breast- and pixel-level models as described
above differentiates our work from approaches which utilize
pixel-level labels in a single differentiable network (16) or
models based on the variations of R-CNN (17). Our approach
allows us to use a very deep auxiliary network at the patch
level, as this network does not have to process the entire high-
resolution image at once. Adding the heatmaps produced by
the patch-level classifier as additional input channels allows the
main classifier to get the benefit from pixel-level labels, while
the heavy computation necessary to produce the pixel-level
predictions does not need to be repeated each time an example
is used for learning. We can also initialize weights of the patch-
level classifier using weights of networks pretrained on large
off-domain data sets such as ImageNet (18).§ Hereafter, we
refer to the model using only breast-level labels as the image-
only model, and the model using breast-level labels and the
heatmaps as the image-and-heatmaps model.
Experiments
In all experiments, we used the training set for optimizing
parameters of our model and the validation set for tuning
hyperparameters of the model and the training procedure.
Unless otherwise specified, results were computed across the
screening population. To obtain predictions for each test
example, we apply random transformations to the input 10
times, apply the model to each of the 10 samples separately
and then average the 10 predictions (details in the SI).
To further improve our results, we employed the technique
of model ensembling (19), wherein the predictions of several
different models are averaged to produce the overall prediction
of the ensemble. In our case, we trained five copies of each
model with different random initializations of the weights
in the fully connected layers. The remaining weights are
initialized with the weights of the model pretrained on BI-
RADS classification, giving our model a significant boost in
performance (details in the SI). For each model, we report the
results from a single network (mean and standard deviation
across five random initializations) and from an ensemble.
Test populations. In the experiments below, we evaluate our
model on several populations to test different hypotheses: (i)
screening population, including all exams from the test set
without subsampling; (ii) biopsied subpopulation, which is
subset of the screening population, only including exams from
the screening population containing breasts which underwent
a biopsy; (iii) reader study subpopulation, which consists of
the biopsied subpopulation and a subset of randomly sampled
exams from the screening population without any findings.
Evaluation metrics. We evaluated our models primarily in
terms of AUC (area under the ROC curve) for malignant/not
malignant and benign/not benign classification tasks on the
breast level. The model and readers’ responses on the subset
for reader study are evaluated in terms of AUC as well as
precision-recall AUC (PRAUC), which are commonly used
metrics in evaluation of radiologists’ performance.
ROC and PRAUC capture different aspects of performance
of a predictive model. The ROC curve summarizes the trade-
off between the true positive rate and false positive rate for
§To finetune a network pretrained on RGB images with grayscale images, we duplicate the grayscale
images across the RGB channels.
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Table 1. AUCs of our models on screening and biopsied populations.
single 5x ensemble
malignant benign malignant benign
screening population
image-only 0.827±0.008 0.731±0.004 0.840 0.743
image-and-heatmaps 0.886±0.003 0.747±0.002 0.895 0.756
biopsied subpopulation
image-only 0.781±0.006 0.673±0.003 0.791 0.682
image-and-heatmap 0.843±0.004 0.690±0.002 0.850 0.696
a model using different probability thresholds. The precision-
recall curve summarizes the trade-off between the true positive
rate (recall) and the positive predictive value (precision) for a
model using different probability thresholds.
Screening population. In this section we present the results
on the screening population, which approximates the distribu-
tion of patients who undergo routine screening. Results are
shown in the first two rows of Table 1. The model ensemble
using only mammogram images achieved an AUC of 0.840 for
malignant/not malignant classification and an AUC of 0.743
for benign/not benign classification. The image-and-heatmaps
model ensemble using both the images and the heatmaps
achieved an AUC of 0.895 for malignant/not malignant and
0.756 for benign/not benign classification, outperforming the
image-only model on both tasks. The discrepancy in perfor-
mance of our models between these two tasks can be largely
explained by the fact that a larger fraction of benign findings
than malignant findings are mammographically-occult (Table
2 in (13)). Additionally, there can be noise in the benign/not
benign labels associated with radiologists’ confidence in their
diagnoses. For the same exam, one radiologist might discard
a finding as obviously not malignant without requesting a
biopsy, while another radiologist might ask for a biopsy.
We find that the image-and-heatmaps model performs bet-
ter than the image-only model on both tasks. Moreover, the
image-and-heatmaps model improves more strongly in ma-
lignant/not malignant classification than benign/not benign
classification. We also find that ensembling is beneficial across
all models, leading to a small but consistent increase in AUC.
Biopsied subpopulation. We show the results of our models
evaluated only on the biopsied subpopulation, in the last two
rows of Table 1. Within our test set, this corresponds to 401
breasts: 339 with benign findings, 45 with malignant findings,
and 17 with both. This subpopulation that underwent biopsy
with at least one imaging finding differs markedly from the
overall screening population, which consists of largely healthy
individuals undergoing routine annual screening without recall
for additional imaging or biopsy. Compared to the results on
the screening population, AUCs on the biopsied population
are markedly lower across all the model variants.
On the biopsied subpopulation, we observed a consistent
difference between the performance of image-only and image-
and-heatmaps models. The ensemble of image-and-heatmaps
models performs best on both malignant/not malignant classi-
fication, attaining an AUC of 0.850, and on benign/not benign
classification, attaining an AUC of 0.696. The markedly lower
AUCs attained for the biopsied subpopulation, in comparison
to the screening population, can be explained by the fact that
exams that require a recall for diagnostic imaging and that
subsequently need a biopsy are more challenging for both
radiologists and our model.¶
Results across ages and breast densities. We divide the test
set by patient age and breast density and evaluate our model
on each subpopulation, as shown in Figure 6. We observe that
the performance of both the image-only and the image-and-
heatmaps models varies across age groups. We also find that
both models perform worse on dense breasts (“heterogeneously
dense” and “extremely dense”) than on fattier ones (“almost
entirely fatty” and “scattered areas of fibroglandular density”),
which is consistent with the decreased sensitivity of radiologists
for patients with denser breasts. Differences in the model’s
performance in benign/not benign classification is larger than
in malignant/not malignant classification. We hypothesize
that this is due to age and breast density influencing the
level of noise in benign/not benign labels, associated with
radiologists’ confidence in their diagnoses.
-50 50-60 60-70 70-
age
0.6
0.7
0.8
0.9
1.0
AU
C
not dense dense
breast density
malignant 
(image-and-heatmaps)
benign 
(image-and-heatmaps)
malignant 
(image-only)
benign 
(image-only)
Fig. 6. AUCs for patients grouped by age and by breast density.
Reader study
To compare the performance of our image-and-heatmaps en-
semble (hereafter referred to as the model) to human radi-
ologists, we performed a reader study with 14 readers—12
attending radiologists at various levels of experience (between
2 and 25 years), a resident and a medical student—each read-
ing 740 exams from the test set (1,480 breasts): 368 exams
randomly selected from the biopsied subpopulation and 372
exams randomly selected from exams not matched with any
biopsy. Exams were shuffled before being given to the readers.
Readers were asked to provide a probability estimate of ma-
lignancy on a 0%-100% scale for each breast in an exam. As
some breasts contain multiple suspicious findings, readers were
asked to give their assessment of the most suspicious finding.
We used the first 20 exams as a practice set to familiarize
readers with the format of the reader study–these were ex-
cluded from the analysis.‖ On the remaining 720 exams, we
evaluated the model’s and readers’ performance on malignancy
classification. Among the 1,440 breasts, there are 62 breasts
labeled as malignant and 356 breasts labeled as benign. In
the breasts labeled as malignant, there are 21 masses, 26 calci-
fications, 12 asymmetries and 4 architectural distortions.∗∗††
¶More precisely, this difference in AUC can be explained by the fact that while adding or subtracting
negative examples to the test population does not change the true positive rate, it alters the false
positive rate. False positive rate is computed as a ratio of false positive and negative. Therefore,
when adding easy negative examples to the test set, the number of false positives will be growing
slower than the number of all negatives, which will lead to an increase in AUC. On the other hand,
removing easy negative examples will have a reverse effect and the AUC will be lower.
‖The readers were shown the images and asked to give their assessment. We confirmed the correct-
ness of the format in which they returned their answers but we did not provide them with feedback
on the accuracy of their predictions.
∗∗Masses are defined as 3-dimensional space occupying lesion with completely or partially convex-
outward borders. Calcifications are tiny specks of calcific deposits. An asymmetry is defined as
a unilateral deposit of fibroglandular tissue that does not meet the definition of mass, i.e., it is an
area of the fibroglandular tissue that is not seen other breast. Architectural distortion refers to a
disruption of the normal random pattern of fibroglandular tissue with no definite mass visible.
††As one breast had two types of findings, the numbers add up to 39, not 38.
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Fig. 7. ROC curves ((a), (b), (c)) and Precision-Recall curves ((a*), (b*), (c*)) on the subset of the test set used for reader study. (a) & (a*): curves for all 14 readers. Their
average performance are highlighted in blue. (b) & (b*): curves for hybrid of the image-and-heatmaps ensemble with each single reader. Curve highlighted in blue indicates the
average performance of all hybrids. (c) & (c*): comparison among the image-and-heatmaps ensemble, average reader and average hybrid.
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Fig. 8. AUC (left) and PRAUC (right) as a function of λ ∈ [0, 1) for hybrids between
each reader and our image-and-heatmaps ensemble. Each hybrid achieves the
highest AUC/PRAUC for a different λ (marked with ♦).
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Fig. 9. Exams in the reader study set represented using the concatenated activations
from the four image-specific columns (left) and the concatenated activations from
the first fully connected layer in both CC and MLO model branches (right).
In the breasts labeled as benign, the corresponding numbers
of imaging findings are: 87, 102, 36 and 6.
Our model achieved an AUC of 0.876 and PRAUC of 0.318.
AUCs achieved by individual readers varied from 0.705 to
0.860 (mean: 0.778, std: 0.0435). PRAUCs for readers varied
from 0.244 to 0.453 (mean: 0.364, std: 0.0496). Individual
ROCs and precision-recall curves, along with their averages
are shown in Figure 7(a) and Figure 7(a*).
We also evaluated the accuracy of a human-machine hybrid,
whose predictions are a linear combination of predictions of a
radiologist and of the model–that is, yhybrid = λyradiologist +
(1 − λ)ymodel. For λ = 0.5‡‡ (see Figure 8 for the results
for λ ∈ [0, 1)), hybrids between each reader and the model
achieved an average AUC of 0.891 (std: 0.0109) and an average
PRAUC of 0.431 (std: 0.0332) (cf. Figure 7(b), Figure 7(b*)).
These results suggest our model can be used as a tool to
assist radiologists in reading breast cancer screening exams
and that it captured different aspects of the task compared to
experienced breast radiologists.
Visualization of the representation learned by the classifier.
Additionally, we examined how the network represents the
exams internally by visualizing the hidden representations
learned by the best single image-and-heatmaps model, for
exams in reader study subpopulation. We visualize two sets
of activations: concatenated activations from the last layer
of each of the four image-specific columns, and concatenated
activations from the first fully connected layer in both CC
and MLO model branches. Both sets of activations have 1,024
dimensions in total. We embed them into a two-dimensional
space using UMAP (20) with the Euclidean distance.
Figure 9 shows the embedded points. Color and size of
each point reflect the same information: the warmer and
‡‡We do not have a way to tune λ to individual readers, hence we chose λ = 0.5 as the most
natural way of aggregating two sets of predictions when not having prior knowledge of their quality.
As Figure 8 shows, an optimal λ varies a lot depending on the reader. The stronger reader’s
performance the smaller the optimal weight on the model. Notably though all readers can be
improved by averaging their predictions with the model for both AUC and PRAUC.
larger the point is, the higher the readers’ mean prediction
of malignancy is. A score for each exam is computed as an
average over predictions for the two breasts. We observe that
exams classified as more likely to be malignant according to
the readers are close to each other for both sets of activations.
The fact that previously unseen exams with malignancies were
found by the network to be similar further corroborates that
our model exhibits strong generalization capabilities.
Related work
Prior works approach the task of breast cancer screening
exam classification in two paradigms. In one paradigm, only
exam-level, breast-level or image-level labels are available. A
CNN is first applied to each of the four standard views and
the resulting feature vectors are combined to produce a final
prediction (14). This workflow can be further integrated with
multi-task learning where radiological assessments, such as
breast density, can be incorporated to model the confidence of
the classification (21). Other works formulate the breast cancer
exam classification task as weakly supervised localization and
produce a class activation map that highlights the locations
of suspicious lesions (22). Such formulations can be paired
with multiple-instance learning where each spatial location is
treated as a single instance and associated with a score that
is correlated with the existence of a malignant finding (23).
In the second paradigm, pixel-level labels that indicate the
location of benign or malignant findings are also provided to
the classifier during training. The pixel-level labels enable
training models derived from the R-CNN architecture (17)
or models that divide the mammograms into smaller patches
and train patch-level classifiers using the location of malignant
findings (16, 24–26). Some of these works directly aggregate
outputs from the patch-level classifier to form an image-level
prediction. A major limitation of such architectures is that
information outside the annotated regions of interest will be
neglected. Other works apply the patch-level classifier as a
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first level of feature extraction on top of which more layers
are stacked and the entire model is then optimized jointly. A
downside of this kind of architecture is the requirement for
the whole model to fit in GPU memory for training, which
limits the size of the minibatch used (usually to one), depth of
the patch-level model and how densely the patch-level model
is applied. Our work is most similar to the latter type of
models utilizing pixel-level labels–however our strategy uses
a patch-level classifier for producing heatmaps as additional
input channels to the breast-level classifier. While we forgo the
ability to train the whole model end-to-end, the patch-level
classifier can be significantly more powerful and can be densely
applied across the original image. As a result, our model has
the ability to learn both local features across the entire image
as well as macroscopic features such as symmetry between
breasts. For a more comprehensive review of prior work, refer
to one of the recent reviews (27, 28).
A variety of results in terms of AUC for prediction of malig-
nancy have been reported in literature. The most comparable
to our work are: (23) (0.86), (17) (0.95), (29) (0.81), (22)
(0.91), (30) (0.84) and (31) (0.89). Unfortunately, although
these results can serve as a rough estimate of model quality,
comparing different methods based on these numbers would
be misleading. Some authors do not discuss design of their
models (29–31), some evaluate their models on very small
public datasets (32, 33), insufficient for a meaningful evalu-
ation, while others used private datasets with populations
of different distributions (on a spectrum between screening
population and biopsied subpopulation), different quality of
imaging equipment and even differently defined labels. By
making the code and the weights of our model public, we seek
to enable more direct comparisons to our work.
Discussion
By leveraging a large training set with breast-level and pixel-
level labels, we built a neural network which can accurately
classify breast cancer screening exams. We attribute this suc-
cess in large part to the significant amount of computation
encapsulated in the patch-level model, which was densely ap-
plied to the input images to form heatmaps as additional input
channels to a breast-level model. It would be impossible to
train this model in a completely end-to-end fashion with cur-
rently available hardware. Although our results are promising,
we acknowledge that the test set used in our experiments is rel-
atively small and our results require further clinical validation.
We also acknowledge that although our network’s performance
is stronger than that of the radiologists’ on the specific task in
our reader study, this is not exactly the task that radiologists
perform. Typically, screening mammography is only the first
step in a diagnostic pipeline, with the radiologist making a
final determination and decision to biopsy only after recall
for additional diagnostic mammogram images and possible
ultrasound. However, in our study a hybrid model including
both a neural network and expert radiologists outperformed
either individually, suggesting the use of such a model could
improve radiologist sensitivity for breast cancer detection.
On the other hand, the design of our model is relatively
simple. More sophisticated and accurate models are possible.
Furthermore, the task we considered in this work, predicting
whether the patient had a visible cancer at the time of the
screening mammography exam, is the simplest possible among
many tasks of interest. In addition to testing the utility of this
model in real-time reading of screening mammograms, a clear
next step would be predicting the development of breast cancer
in the future–before it is even visible to a trained human eye.
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Additional analysis of results
We detail in this section additional results and analyses to supplement the results in the main paper.
Heatmaps-only model. We evaluate the relative benefit of including images and heatmaps as inputs to our model by also
considering a model variant where the model only takes as input the patch classification heatmaps, without being shown
the original mammogram. The results are shown in Table S1. We see that the heatmaps-only model performs comparably
with the image-only model on malignant/not malignant classification, while significantly underperforming on benign/not
benign classification. We speculate that this discrepancy arises from the higher prevalence of mammographically occult benign
findings. The patch classification models are trained on classifying patches based on pixel-level segmentations, which contain
a higher density of label information compared to breast-level labels and thus provide a stronger learning signal, leading to
better performance on malignant/not malignant prediction. On the other hand, because benign findings are more likely to
be mammographically occult (see Table 2 in (1)), these cases cannot be segmented and hence are not present in the patch
dataset–the patch classification model is thus less well-conditioned to those benign findings. Conversely, the image-only model
is still shown the benign labels derived from biopsies, and may thus pick up on visual clues suggesting a benign finding despite
the cases being considered mammographically occult by radiologists. The superior performance of the heatmaps-only model
over the image-only model on malignant/not-malignant classification also suggests that the increased depth of the model and
the more strongly supervised nature of the patch classification task outweighs the benefits of training a deep model end-to-end.
In addition, we observe a much smaller benefit to ensembling the heatmaps-only models compared to the image-only and
image-and-heatmaps models. The intuition behind this observation is that the heatmaps have likely already distilled most
of the pertinent information for cancer classification. We speculate that because the heatmaps-only model learn a simpler
transformation to target cancer classification, there is lower model diversity and thus a smaller benefit from ensembling.
Above all, the image-and-heatmaps model still remains the strongest overall model, demonstrating that effectively utilizing
both local and global visual information leads to superior performance on the cancer classification problem.
Table S1. AUCs of model input variants on screening and biopsied populations.
single 5x ensemble
malignant benign malignant benign
screening population
image-only 0.827±0.008 0.731±0.004 0.840 0.743
heatmaps-only 0.837±0.010 0.674±0.007 0.835 0.691
image-and-heatmaps 0.886±0.003 0.747±0.002 0.895 0.756
biopsied population
image-only 0.781±0.006 0.673±0.003 0.791 0.682
heatmaps-only 0.805±0.007 0.621±0.008 0.803 0.633
image-and-heatmaps 0.843±0.004 0.690±0.002 0.850 0.696
Correlation between model predictions. We visualize in Figure S1 the correlations between model predictions for the four
different labels (left-benign, left-malignant, right-benign, right-malignant) for a given exam. In both image-only and image-
and-heatmaps model ensembles, we observe high correlations between benign and malignant predictions for the same breast,
and low correlations for predictions between breasts. Notably, we observe a lower correlation between benign and malignant
predictions for the same breast in the image-and-heatmaps model ensemble compared to the image-only model ensemble. This
is consistent with other results showing that the image-and-heatmaps models are better able to distinguish between benign and
malignant cases, likely due to the additional information from the class-specific heatmaps.
Comparison of CC and MLO model branches. The architecture of our model can be decomposed into two separate but symmetric
deep neural network models, operating on CC view and MLO view images respectively, which we refer to as the CC and MLO
branches of the model. Each branch individually computes predictions for all four labels, and the full model’s final prediction
is the average of the predictions of both branches. We show in Table S2 the breakdown of the performance of the CC and
MLO branches of our model. We observe a fairly consistent trend of the CC model branch outperforming the MLO model
branch, across multiple contexts (malignant/not malignant classification, benign/not benign classification, with or without the
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Fig. S1. Correlations of model ensemble predictions across labels.
Table S2. AUCs of CC and MLO model branches on screening and biopsied populations.
single 5x ensemble
malignant benign malignant benign
screening population
image-only 0.827±0.008 0.731±0.004 0.840 0.743
image-only (CC) 0.813±0.009 0.726±0.004 0.830 0.739
image-only (MLO) 0.766±0.012 0.691±0.006 0.776 0.705
image-and-heatmaps 0.886±0.003 0.747±0.002 0.895 0.756
image-and-heatmaps (CC) 0.873±0.006 0.740±0.005 0.891 0.752
image-and-heatmaps (MLO) 0.834±0.002 0.703±0.002 0.847 0.712
biopsied population
image-only 0.781±0.006 0.673±0.003 0.791 0.682
image-only (CC) 0.774±0.006 0.677±0.003 0.786 0.687
image-only (MLO) 0.732±0.012 0.638±0.002 0.743 0.649
image-and-heatmaps 0.843±0.004 0.690±0.002 0.850 0.696
image-and-heatmaps (CC) 0.833±0.004 0.690±0.004 0.847 0.699
image-and-heatmaps (MLO) 0.802±0.003 0.650±0.002 0.813 0.656
heatmaps). The superior performance of the CC model branch is consistent with the view of radiologists that findings may
be more conspicuous and better visualized in the CC view compared to the MLO view. The predictions of the full model
generally outperform using the predictions of either branch individually, except in the case of benign prediction for the biopsied
population, where the CC model branch slightly outperforms the averaged prediction.
Classifying malignant/benign vs. normal. In this section and the next, we further analyze the behavior of our model by
decomposing the task of breast cancer classification into two sub-tasks: (i) determining if a breast has any findings, benign or
malignant, and (ii) conditional on the presence of a finding, determining whether it is malignant or benign.
First, we evaluated our models on the task of only predicting whether a single breast has either a malignant or a benign
finding, or otherwise (negative for both malignant and benign findings). This is equivalent to predicting whether, for a given
screening mammogram, a biopsy was subsequently performed. This evaluation is performed over the screening population.
Without retraining the model, we took the maximum of malignant and benign predictions as the prediction of a biopsy.
We obtained an AUC of 0.767 using the image-and-heatmaps model ensemble, with more results shown in Table S3. The
relatively small margin in performance between the image-only and image-and-heatmaps models indicates that the heatmaps
are marginally less useful for the task of determining the presence of any finding at all.
Table S3. AUCs of our models on screening and biopsied populations, on the task of classifying malignant/benign vs normal.
single 5x ensemble
image-only 0.740±0.003 0.752
image-and-heatmaps 0.759±0.002 0.767
Classifying malignant vs. benign. Next, we investigated the ability of our models to distinguish between malignant and benign
findings on exams where we know there is a mammographically visible finding–this isolates the discriminative capability
of our model between types of findings. We constructed the one-class biopsied subpopulation, with a subset of 384 breasts
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from our test set, comprising only of breasts labeled either only malignant or only benign. We evaluate our models on the
ability to predict whether a finding in a given breast was malignant or benign. To adapt the predictions of our model to this
binary classification task, we normalized the prediction probabilities for the two classes to sum to one and calculated AUCs
based on these normalized predictions. The image-only ensemble attained an AUC of 0.738 while the image-and-heatmaps
ensemble attained an AUC of 0.803. This, along with the results above, provides evidence that the heatmaps help primarily in
distinguishing between benign and malignant findings.
Additional reader study analysis. We supplement the results of our reader study shown in the main paper with additional
analysis in this section.
Reader ensemble and hybrid ensemble. We evaluate a reader ensemble by averaging the predictions across our 14 readers. We
also evaluate a hybrid ensemble by averaging the predictions of the ensemble of readers with our image-and-heatmaps model
ensemble, where we equally weight both sets of predictions. Figure S2 shows the ROC curves and precision-recall curves of
these two ensembles compared to our model ensemble alone. We observe that the hybrid ensemble outperforms the reader
ensemble based on AUC, but underperforms based on PRAUC. This suggests that although the combination of our model a
single radiologist tends to lead to improved accuracy, the benefit that our model could provide to a group of radiologists is far
more limited.
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Fig. S2. ROC curves and precision-recall curves of reader ensemble, hybrid ensemble and our image-and-heatmaps model ensemble.
Representation learned by image-only model. We visualize the hidden representations learned by the best image-only model in
addition to the best image-and-heatmaps model, computed on the same reader study subpopulation (cf. Figure S3). Compared
to the distribution of representations learned by the image-and-heatmaps model, exams classified as more likely to be malignant
according to readers were spread more randomly over the space but group together in several clusters. This pattern is apparent
in both sets of activations, and suggests that the learned representational space that the mammograms are projected to are
better conditioned for malignancy classification for the image-and-heatmaps model compared to the image-only model.
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Fig. S3. Exams in the reader study set represented using the concatenated activations from the four image-specific columns (left) and the concatenated activations from the
first fully connected layer in both CC and MLO model branches (right). The above activations are learned by the best image-only model.
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Error analysis. To further understand the performance of our image-and-heatmaps model ensemble (referred to as the model for
the remainder of this section), especially its medical relevance, we conducted the following detailed analysis on nine breasts
comprised of examples which were classified incorrectly but confidently by the model. These includes false positive cases for
malignancy (cf. Figure S4, Figure S5, Figure S6) and false negative cases for malignancy (cf. Figure S7, Figure S8, Figure S9), as
well as examples where the model strongly disagreed with the average predictions of the 14 readers (cf. Figure S10, Figure S11,
Figure S12). Examples are shown with annotated lesions, both heatmaps, and a brief summary of the model’s and readers’
predictions.
The case in Figure S4 succinctly illustrates the ambiguity in medical imaging. Both the model and readers were highly
confident in predicting cancer, but the result of the biopsy was a high-risk benign finding. Further evidence for ambiguity is
found in Figure S8, where both the model and readers predicted that the calcifications were benign. Although the findings
appear relatively benign on screening mammography, radiologists often recommend a biopsy of low suspicion calcifications
(>2-10% chance of malignancy) due to the known wide variation in the appearance of malignant calcifications and the
opportunity to identify an early, more treatable cancer. Above all, some of the model’s false negative and false positive cases
can be explained as evidence for the inherent ambiguity in imaging, which highlights that screening mammography may not be
sufficient to determine the correct diagnosis for certain findings.
In Figure S12, the readers’ scores for malignancy are consistently low while the score given by our model is 0.590. In fact,
the small mass marked in green on the image turned out to be benign, while on the diagnostic mammogram, the area marked
in red looked more suspicious and turned out to be a cancer. This case illustrates the strength of our model–when multiple
suspicious findings are present and some are more obvious and easier to determine, human readers may be fatigued from
reading a series of mammograms and could be more prone to error by not fully considering each suspicious finding. Figure S6
is another good example from this perspective when a finding presents differently on two views. Upon a retrospective review by
a radiologist, the smaller faint calcifications on the MLO view indeed appear suspicious, whereas readers may have focused on
the CC view that look benign during the reader study.
Our model still lacks the ability to summarize information about changes from multiple images and views. Some cases with
incorrect predictions could be summarized from this perspective, such as Figure S5 and Figure S9. In Figure S5, while the
radiologist confidently thought that the case would be benign, since even the distribution of the calcification was particularly
suspicious on one image, this did not hold up on additional images. In Figure S9, the model may have missed the malignant
finding because it only appeared highly suspicious on the MLO view, but experienced doctors still caught it with high confidence.
However, in Figure S10, our model shows its potential in utilizing both global and local information. According to radiologists,
the case looks very suspicious, especially on MLO view, where there is a white mass with irregular margins (termed architectural
distortion). However, the pathology was benign. The model indeed provided a low score for a malignant finding and a high
score for a benign finding. While the ‘malignant’ heatmap appeared more correlated with the area under the yellow mask for
both views, the ‘benign’ heatmap was widely distributed with high magnitude.
Figure S7 is an example of a false negative for the model. Although we obverse an overlap between the region highlighted
by the the ‘malignant’ heatmap and the lesion, the model’s prediction for malignant findings is low while the its prediction for
benign findings is higher than 0.5. However, there is an asymmetry with architectural distortion on both views–an imaging
feature that has a high probability of malignancy. Hence, radiologists assigned a high malignancy score.
Another case where readers were more confident than the model is Figure S11. The mass in the right breast appears
suspicious because it has an architectural distortion. In addition, its location at the bottom from the MLO view (inferior
breast), and its medial location from the CC view makes it highly suspicious. In this scenario, radiologists incorporated
information from the global view of the mammogram in making their assessment about the likelihood of malignancy for this
case.
Network architecture and training
We detail in this section the model architecture, training procedure and hyperparameters associated with training our deep
convolutional neural network for cancer classification.
Breast-level cancer classification model. We use a single classification model to generate predictions for each of the four labels
of an exam, corresponding to the presence of findings in either breast (left-benign, left-malignant, right-benign, right-malignant).
The model takes as input a set of four single-channel images, corresponding to the four standard mammographic views (R-CC,
L-CC, R-MLO, L-MLO). We use an input resolution of 2677× 1942 pixels for CC views, and 2974× 1748 pixels for MLO views,
based on the optimal window procedure described in (1). When additionally using the heatmaps produced by the auxiliary
network learning from patch-level labels, we concatenate them as extra input channels to the corresponding views, resulting in
three channels in total: the image, the ‘benign’ patch classification heatmap, and the ‘malignant’ patch classification heatmap.
The model is composed of four view-specific columns, each based on the ResNet architecture (2) that computes a fixed-
dimension hidden representation for each view. Weights are shared between the L-CC and R-CC columns, and L-MLO and
R-MLO columns regardless of model variant. The output of the model is four separate binary probability estimates–one for
each of the four labels.
We initialized the weights of the view-specific columns by pretraining with BI-RADS labels (see section below), and randomly
initialized the rest. We trained the whole model using stochastic gradient descent with the Adam optimization algorithm (3),
using a learning rate of 10−5 and a minibatch of size 4. Our loss function was cross-entropy averaged across all four labels. We
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Fig. S4. A biopsy-proven high-risk benign finding
marked in yellow on both CC (top row) and MLO views
(the second row) in the patient’s right breast. The
heatmaps overlying the images (green for benign and
red for malignant) are shown after the images with seg-
mentation. The malignant score for this breast given
by the model is 0.997 while the benign score is 0.909.
The ‘malignant’ heatmap highlighted the marked area
but the ‘benign’ heatmap did not, for both CC and MLO
views. The mean malignant score given by the 14
readers is 0.699, with 12 readers giving scores over
0.6.
Fig. S5. A region with biopsy-proven high-risk benign
findings marked in yellow on both the CC view and
the MLO view in the patient’s left breast. Images and
heatmaps are shown with the same layout as in Fig-
ure S4. Compared with the case in Figure S4, the gap
between the malignant and benign scores given by
the model for this breast is larger–the malignant score
is 0.709 and the benign score is 0.433. The highest
malignant scores given by the 14 readers is 0.25 and
the mean is only 0.03.
Fig. S6. A biopsy-proven benign finding marked in
green on both the CC view and the MLO view in the
patient’s left breast. Images and heatmaps are shown
with the same layout as in Figure S4. The malignant
score for this breast given by the model is 0.735 while
the benign score is 0.549. Readers were highly confi-
dent that this case was benign and their mean malig-
nant score is 0.05, with the highest score being only
0.2.
Fig. S7. A biopsy-proven malignant finding marked in
red on both the CC view and the MLO view in the pa-
tient’s right breast. Images and heatmaps are shown
with the same layout as in Figure S4. The malignant
score for this breast given by the model is 0.210 while
the benign score is 0.621. Doctors’ mean malignant
score is 0.459 and eight readers among the 14 pro-
vided a score higher than 0.5.
Fig. S8. A biopsy-proven malignant finding marked
in red on both the CC view and the MLO view in the
patient’s left breast. And the breast was also labeled as
benign according to related pathology reports. Images
and heatmaps are shown with the same layout as in
Figure S4. The malignant score given by the model is
0.068 and benign score is 0.433. The mean malignant
score given by the 14 readers is 0.176, with the highest
being only 0.30.
Fig. S9. A biopsy-proven high-risk benign finding
marked in yellow and a malignant finding marked in red
on both the CC view and the MLO view in the patient’s
right breast. Images and heatmaps are shown with the
same layout as in Figure S4. The malignant score for
this breast given by the model is only 0.044 while the
benign score is 0.162. Doctors were confident that it
was highly suspicious–their mean malignant score is
0.698 and 10 of them provided a probability estimate
over 0.5.
applied L2-regularization to our model weights with a coefficient of 10−4.5. As only a small fraction of the exams in our training
set contained images of biopsied breasts, learning with all data in the training set would be extremely slow as the model would
only be shown a relatively small number of positive examples per epoch. To alleviate this issue, we adopted the following two
strategies. First, while we trained the cancer classification model on data from all screening exams, within each training epoch,
the model was shown all exams with biopsies in the training set (4,844 exams) but only a random subset of an equal number of
exams without biopsies (also 4,844 exams) (4). Secondly, as mentioned above, we initialized the ResNet weights of the cancer
classification model from a model trained on BI-RADS classification, a task for which we have labels for all exams.
We early-stopped the training when the average of the validation AUCs over the four labels computed on the validation set did
not improve for 20 epochs. We then selected the version of the model with the best validation AUC as our final model candidate.
We show the training and validation curve for one image-only model and one image-and-heatmaps model in Figure S13.
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Fig. S10. A biopsy-proven high-risk benign finding
marked in yellow on both the CC view and the MLO
view in the patient’s left breast. Images and heatmaps
are shown with the same layout as in Figure S4. The
malignant score for this breast given by the model is
0.124 and the benign score is 0.530. Readers’ mean
malignant score is 0.763.
Fig. S11. A biopsy-proven malignant finding marked in
red and a benign finding marked in green on both the
CC view and the MLO view in the patient’s right breast.
Images and heatmaps are shown with the same layout
as in Figure S4. The malignant score given by the
model is 0.702 and the benign score is 0.682. Mean
malignant score given by readers is 0.978 and ten of
them gave a score over 0.9.
Fig. S12. A biopsy-proven benign finding marked in
green on both CC view (top row) and MLO view (the
second row) and a malignant finding marked in red
only on CC view, in the patient’s right breast. Images
and heatmaps are shown with the same layout as in
Figure S4. The malignant score for this breast given
by the model is only 0.590 while the benign score is
0.557. The readers’ mean malignant score is 0.071,
with the highest score being only 0.3.
For the training curve, we computed the AUC of each prediction and corresponding label (e.g. left breast/CC/benign) and
average across the breast sides and CC/MLO branches. The AUC is computed on a training data subsample that has an
equal number of biopsied and non-biopsied examples. We do the same for the validation curve, except we compute the AUC
on the full validation data set. Because of the difference in distributions, the training and validation AUC curves are not
directly comparable–we refer the reader to the discussion in the main paper on how differences in the proportion of biopsied
examples can significantly influence AUC calculations. We observe that the image-and-heatmap model attains higher training
and validation AUC for malignancy prediction compared to the image-only model, whereas the AUCs for benign prediction are
not significantly different between the image-and-heatmaps and image-only models.
The full image-only model has 6,132,592 trainable parameters, while the image-and-heatmaps model has 6,135,728 trainable
parameters. The only difference between both architectures is the size of the kernel in the first convolutional layer to
accommodate the difference in the number of input channels. On an Nvidia V100 GPU, an image-only model takes about 12
hours to train to the best validation performance, while an image-and-heatmaps model takes about 24 hours. A significant
amount of training overhead is associated with the time to load and augment the high resolution mammography images.
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Fig. S13. Training curves for image-only and image-and-heatmaps models. AUCs are averaged across prediction heads and target labels. Training AUCs are computed on
subsampled data with an equal number of biopsied and randomly subsampled non-biopsied examples, while validation AUCs are computed on the full validation set.
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Data augmentation for model training
Data augmentation is often applied in training deep neural networks to increase the diversity of the training data samples
to improve the robustness of the trained model. We apply size augmentation (slightly modifying the crop window size, and
resizing using bicubic interpolation to fit the desired size for the model) and location augmentation (adding noise around the
chosen optimal center of the window). Examples can be found in Figure S14. We limited the maximum value for both size and
location augmentation to 100 pixels in any direction. If the image was too small to apply augmentation, we additionally pad
the images to allow enough room.
At test time, we similarly apply data augmentation, and average predictions over 10 random augmentations to compute the
prediction for a given sample. No data augmentation is used during validation.
Fig. S14. Example of drawing 10 augmentation windows with random noise in the location and size of the windows.
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Fig. S15. Four model variants for incorporating information across the four screening mammography views in an exam. All variants are constrained to have a total of 1,024
hidden activations between fully connected layers. The ‘view-wise’ model, which is the primary model used in our experiments, contains separate model branches for CC and
MLO views–we average the predictions across both branches. The ‘image-wise’ model has a model branch for each image, and we similarly average the predictions. The
‘breast-wise’ model has separate branches per breast (left and right). The ‘joint’ model only has a single branch, operating on the concatenated representations of all four
images.
Model variants. Based on the four view-specific hidden representations, we considered four model variants for incorporating the
information from all four views in producing our output predictions. The full architectures of the four variants are shown in
Figure S15. The ‘view-wise’ model concatenates L-CC and R-CC representations, and L-MLO and R-MLO representations,
and uses separate CC and MLO prediction heads to generate predictions for all four labels. This is the model used in the main
paper, chosen based on validation performance on the screening population. The ‘image-wise’ model has separate prediction
heads for each of the four views, predicting only the malignant or benign labels for the corresponding breast. The ‘side-wise’
model concatenates L-CC and L-MLO representations, and R-CC and R-MLO representations, and has separate prediction
heads for each breast. Lastly, the ‘joint’ model concatenates the representations of all four views and jointly predicts malignant
and benign findings for both breasts. Regardless of architecture, each model consists of two fully connected layers that produce
four probability estimates–one for each of the four labels.
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Table S4. AUC of model variants on screening and biopsied populations.
single 5x ensemble
malignant benign malignant benign
screening population
image-only (view-wise) 0.827±0.008 0.731±0.004 0.840 0.743
image-only (image-wise) 0.830±0.006 0.759±0.002 0.841 0.766
image-only (breast-wise) 0.821±0.012 0.757±0.002 0.836 0.768
image-only (joint) 0.822±0.008 0.737±0.004 0.831 0.746
image-and-heatmaps (view-wise) 0.886±0.003 0.747±0.002 0.895 0.756
image-and-heatmaps (image-wise) 0.875±0.001 0.765±0.003 0.885 0.774
image-and-heatmaps (breast-wise) 0.876±0.004 0.764±0.004 0.889 0.779
image-and-heatmaps (joint) 0.860±0.008 0.745±0.002 0.876 0.763
biopsied population
image-only (view-wise) 0.781±0.006 0.673±0.003 0.791 0.682
image-only (image-wise) 0.740±0.007 0.638±0.001 0.749 0.642
image-only (breast-wise) 0.726±0.009 0.639±0.002 0.738 0.645
image-only (joint) 0.780±0.006 0.682±0.001 0.787 0.688
image-and-heatmaps (view-wise) 0.843±0.004 0.690±0.002 0.850 0.696
image-and-heatmaps (image-wise) 0.812±0.001 0.653±0.003 0.821 0.658
image-and-heatmaps (breast-wise) 0.805±0.004 0.652±0.004 0.818 0.661
image-and-heatmaps (joint) 0.817±0.008 0.696±0.005 0.830 0.709
We show results across different model variants in Table S4, evaluated on the screening population. Overall, all four model
variants achieve high and relatively similar AUCs. The ‘view-wise’ image-and-heatmaps ensemble, which is also architecturally
most similar to the BI-RADS model used in the pretraining stage, performs the best in predicting malignant/not malignant,
attaining an AUC of 0.895 on the screening population and 0.850 on the biopsied population. However, some of the other model
variants do outperform the ‘view-wise’ ensemble for benign/not-benign prediction. Among the image-only models, the four
model variants perform roughly comparably, though still consistently underperforming the image-and-heatmaps models. We
emphasize that the ‘view-wise’ model was chosen as the model shown in the main paper based on the average of malignant/not
malignant and benign/not benign AUCs on the validation set, and not based on test set results.
Constructing an ensemble of the four model variants for the image-and-heatmaps model, with five randomly initialized
models per variant,∗ results in an AUC of 0.778 on benign/not benign prediction, and 0.899 on malignant/not malignant
prediction on the screening population. Although this performance is superior to any individual model variant, running such a
large ensemble of 20 separate models would be prohibitively expensive in practice.
Single-view ResNet. The overall model consists of four separate ResNet (2) models corresponding to each of the four views. In
this section, we describe the structure of these ResNets. The full architecture of each ResNet is shown in Figure S16. We tied
the weights for the L-CC and R-CC ResNets, as well as the L-MLO and R-MLO ResNets. Likewise, we flipped the L-CC and
L-MLO images before feeding them to the model, so all breast images are rightward-oriented, allowing the shared ResNet
weights to operate on similarly oriented images.
The output of each ResNet is a H ×W × 256-dimensional tensor where H and W are downsampled from the original
input size, with H=42 and W=31 for the CC view, and H=47 and W=28 for MLO view. We average-pool across the spatial
dimensions to obtain a 256-dimension hidden representation vector for each view. For reference, we show the dimensions of the
hidden activations after each major layer of the ResNet in Table S5.
Table S5. Dimensions hidden of activation after each layer in the ResNet, shown as D ×H ×W .
CC view MLO view
Conv7x7 1339×971×16 1487×874×16
ResBlock 0 670×486×16 744×437×16
ResBlock 1 335×243×32 372×219×32
ResBlock 2 168×122×64 186×110×64
ResBlock 3 84×61×128 93×55×128
ResBlock 4 42×31×256 47×28×256
Pretraining on BI-RADS classification. Because of the small number of labeled biopsied examples we have available, we apply
transfer learning to improve the robustness and performance of our models. Transfer learning involves reusing parts of a model
pretrained on another task as a starting point for training the target model, taking advantage of the learned representations
from the pretraining task.
∗Only the weights in the fully connected layers are randomly initialized–we use the same set of pretrained BI-RADS weights to initialize ResNet columns in all experiments, excluding the experiments with
models without BI-RADS pretraining.
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Fig. S16. Architecture of single-view ResNet. The numbers in square brackets indicate the number of output channels, unless otherwise specified. Where no downsampling
factor is specified for a ResNet block, the downsampling layer reduces to a 1x1 convolution. Left: Overview of the single-view ResNet, which consists of a set of ResNet layers.
Center: ResNet layers consist of a sequence of ResNet blocks with different downsampling and output channels. Right: ResNet blocks consist of two 3x3 convolutional layers,
with interleaving downsampling and batch normalization operations, and a residual connection between input and output.
For our model, we apply transfer learning from a network pretrained on a BI-RADS classification task, as in (5), which
corresponds to predicting a radiologist’s assessment of a patient’s risk of developing breast cancer based on screening
mammography. The three BI-RADS classes we consider are: BI-RADS Category 0 (“incomplete”), BI-RADS Category 1
(“normal”) and BI-RADS Category 2 (“benign”). The algorithm used to extract these labels is explained in (1). Although these
labels are potentially much noisier than biopsy outcomes (being assessments of clinicians based on screening mammograms and
not informed by a biopsy), compared to the 4,844 exams with biopsy-proven cancer labels in the training set, we have over
99,528 training examples with BI-RADS 0 and BI-RADS 2 labels. As shown in (6), a few thousand training exams may be
insufficient to learn millions of parameters in CNN architectures–instead, convolutional layers can be pretrained as a “generic
extractor of mid-level image representation" and thereafter reused. On the other hand, although the BI-RADS labels are noisy,
neural networks can reach reasonable levels of performance even when trained with noisy labels, as shown in (7) and (8),
and the information learned can then be transferred to the cancer classification model. In fact, our experiments show that
pretraining on BI-RADS classification contributes significantly to the performance of our model.
The model we use for BI-RADS classification is shown in Figure S17. It is largely similar to the ‘view-wise’ model architecture
for cancer classification described in the Model variants section above, except that the output layer outputs probability estimates
over three classes for a single label. Although the BI-RADS classification task is a three-class classification task, we measured
the performance of the model by averaging AUCs of 0-vs-other, 1-vs-other and 2-vs-other predictions on the validation set.
The rest of the training details (e.g. ResNet architecture, optimizer hyperparameters) are identical to those of the cancer
classification model, except that the model was trained with a minibatch size of 24 instead of 4. We early-stopped training
based on validation AUCs after no improvements for 20 epochs, and initialized the ResNet weights for the cancer classification
model using the learned weights in the BI-RADS model. Where we used heatmaps as additional input channels, we duplicated
the weights on the bottommost convolutional kernel such that the model can operate on inputs with three channels–the rest of
the model is left unchanged. In our experimental results, we used a BI-RADS model trained for 111 epochs (326 hours or
approximately 14 days on four Nvidia V100 GPUs), which obtained an averaged validation AUC of 0.748.
We emphasize here that we used the same train-validation-test splits for pretraining our BI-RADS classification model as in
training our cancer classification model, so no data leakage across splits was possible.
Cancer classification model without BI-RADS pretraining. In this section, we evaluate the benefit of the BI-RADS pretraining by
comparing the performance of our models to cancer classification models trained without using weights from a pretrained
BI-RADS model. Specifically, we train a set of cancer classification models by starting from entirely randomly initialized model
weights.
The results are shown in Table S6. In every case, we see an improvement in performance from using weights of a model
pretrained on BI-RAD classification, compared to randomly initializing the model weights and training from scratch. The
improvement in performance from using pretrained weights tends to be larger for the image-only model compared to image-
and-heatmaps models. We hypothesize that this is because the heatmaps already contain significant information pertaining to
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Fig. S17. BI-RADS classification model architecture. The architecture is largely similar to the ‘view-wise’ cancer classification model variant, except that the output is a set of
probability estimates over the three output classes. The model consists of four ResNet columns, with weights shared within CC and MLO branches of the model.
cancer classification, and hence the model can likely more quickly learn to make use of the heatmaps for cancer classification. In
contrast, the image-only models rely entirely on the ResNets to effectively encode visual information for cancer classification, and
therefore using the weights of a model pretrained for BI-RADS classification contributes significantly to the model performance.
Table S6. AUCs of our models on screening and biopsied populations, with and without BI-RADS pretraining.
single 5x ensemble
malignant benign malignant benign
screening population
image-only (pretrained) 0.827±0.008 0.731±0.004 0.840 0.743
image-only (random) 0.687±0.009 0.657±0.006 0.703 0.669
image-and-heatmaps (pretrained) 0.886±0.003 0.747±0.002 0.895 0.756
image-and-heatmaps (random) 0.856±0.007 0.701±0.004 0.868 0.708
biopsied population
image-only (pretrained) 0.781±0.006 0.673±0.003 0.791 0.682
image-only (random) 0.693±0.006 0.564±0.006 0.709 0.571
image-and-heatmaps (pretrained) 0.843±0.004 0.690±0.002 0.850 0.696
image-and-heatmaps (random) 0.828±0.008 0.633±0.006 0.841 0.640
Details of the auxiliary patch-level classifier
We used a dataset of 5,000,000 patches to train the auxiliary patch-level classification network to classify patches into one of
four classes: (i) patches overlapping only with area segmented by annotations in red, indicating malignant findings (malignant);
(ii) patches overlapping only with area segmented by annotations in green or yellow, indicating benign findings (benign); (iii)
patches from segmented images but not overlapping with any marked area (outside); (iv) patches from images in exams labeled
as negative for both benign and malignant (negative). As described in (1), the findings were manually indicated on the images
by radiologists on a pixel-level, based on results from pathology. Images which are mammographically occult, i.e., the lesions
that were biopsied were not visible on the image, were not taken into consideration while generating this training set.
Sampling the patches. Patches in the dataset were generated from all available mammography exams in the training set–the
same as those used to train the breast-level model. Before extracting the patches, images were all cropped according to the
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(a) Malignant. Examples of patches overlapping only with biopsied malignant
findings (marked with red).
(b) Benign. Examples of patches overlapping only with biopsied benign findings
(marked with yellow or green).
(c) Outside. Examples of patches from images with biopsied findings but without
an overlap with any biopsied findings.
(d) Negative. Examples of patches from images without any biopsied findings.
Fig. S18. Examples of patches sampled according to the procedure described in the Sampling the patches section. From (a) to (d), four patches are shown with the images of
their origin, for four classes: malignant, benign, outside and negative. Patches are shown on the left, while the images of origin (with indicated biopsied findings if any were
present) are on the right. The blue squares indicate the location of the patches in the original images. The meaning of the colored regions on the images is described in a
greater detail in (1).
algorithms described in (1). As was the case for the breast-level model, we flipped the L-CC and L-MLO images so that all
breast images were rightward-oriented. Each patch was cropped as a square from a full-size image. To sample a patch, we first
sampled a location for the center of the patch, then sampled its size from a uniform distribution between 128 pixels and 384
pixels and finally sampled an angle by which the crop window was rotated, also from a uniform distribution from -30 to 30
degrees. A sample was rejected if it contained any pixels outside of the full-size image or only contained zero-valued pixels (i.e.
containing only background and no breast tissue). Once extracted, the patches were resized to 256×256 pixels. Examples are
shown in Figure S18.
Training and architecture. We used a DenseNet-121 architecture (9) for our patch-level auxiliary classifier, with four dense blocks
with 6, 12, 24, 16 dense layers respectively. The entire network has approximately seven million parameters. We initialized the
weights of the model with the weights of a DenseNet-121 trained on ImageNet.
The number of images with visible biopsied findings is small (0.85%) in comparison to the total number of images.
Furthermore, the fraction of the total image area associated with visible biopsied findings is also small (0.87%, averaging above
images with segmentation). To accommodate this, in each training epoch, we randomly sampled 10,000 patches: 20 from
the malignant class, 35 from the benign class, 5,000 from the outside class and 4,945 from the negative class. This ratio of
malignant, benign, outside and negative patches was chosen to reflect the ratio of aream, areab, areao and arean, which are
the sums of the respective fractions of total areas over our segmented training data set. aream and areab denote the total
sum of the area under biopsied malignant and benign findings respectively over the entire 6, 758 images with segmentation in
the training set. Accordingly, the sum of the remaining area is denoted by areao. 7,000 images without any segmentation were
randomly sampled and arean denotes the sum of the size of all those images. In order to address the extreme class imbalance,
we used weighted cross-entropy as the training loss, wherein the class weights were set as the inverse of the above patch ratio
so that losses on incorrect predictions of malignant and benign patches were appropriately upweighted. Weighted cross-entropy
loss has the following form:
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L(x) =
∑
c
wc log pˆc(x),
where x is the input image, c is the class label assumed to be in {malignant (m), benign (b), outside (o), negative (n)} and
pˆc(x) is the probability of class c predicted by the network. The coefficient wc is computed as
wc =
Πk Ó=cNk∑
j∈m,b,o,n Πk Ó=jNk
,
where Nk is the number of patches for class k.
We trained the network using the Adam optimization algorithm (3), with a batch size of 100 and a learning rate of 10−5.
Patch classification heatmap generation. The patch-level auxiliary classifier is applied to the full resolution images in a sliding
window fashion to create two class-specific heatmaps, corresponding to the malignant and benign predictions of the patch-level
classifier. Since mammography images vary in sizes (before cropping is applied to use them as an input for the model), to slide
the classifier over the image, we used Algorithm 1 to compute the appropriate values of the strides for vertical and horizontal
dimensions. We applied strides of approximately 70 pixels wide across both dimensions. We used non-augmented 256× 256
patches as inputs to the patch classifier. For each patch, we projected the respective predicted class probabilities to the original
256× 256 input area of each patch, and we averaged the predicted probabilities for pixels in overlapping patches. Ultimately,
we generate two heatmaps for each image–one for prediction of malignancy and one for prediction of benign findings. Both
are passed as additional input channels to the breast-level model. The predicted probabilities for outside and negative patch
classes are not used here.
Algorithm 1 Strides setting
1: function strides_setting(image_size)
2: prefixed_stride = 70
3: patch_size = 256
4: sliding_steps = (image_size - patch_size) // prefixed_stride
5: pixel_remaining = (image_size - patch_size) % prefixed_stride
6: if pixel_remaining == 0 then
7: stride_list = [prefixed_stride] * sliding_steps
8: else
9: sliding_steps += 1
10: pixel_overlap = prefixed_stride - pixel_remaining
11: stride_avg = prefixed_stride - pixel_overlap // sliding_steps
12: stride_list = [stride_avg] * sliding_steps
13: randomly choose number of pixel_overlap % sliding_steps items from stride_list and decrement 1 for each.
return stride_list
Model evaluation and selection. The main purpose of the patch-level classifier is to generate heatmaps which can be used as extra
channels for the breast-level classifier. Unfortunately, it is hard to evaluate the patch-level classifier with respect to how it
improves the breast-level model at each epoch. We trained the patch-level network for 2,000 epochs, saving its parameters
every 200 epochs. The 10 models saved were used to generate malignant and benign heatmaps for all images in the validation
set. To form a breast-level prediction for the malignant/not malignant task from the heatmaps, we took the maximum value
across the malignant heatmaps for each breast. The breast-level predictions for the benign/not benign task were computed
analogously. The model we used for generating heatmaps for the entire data set was selected based on the average of the
AUCs (between the two tasks) we obtained using these predictions. The process of generating the heatmaps for the entire
dataset took approximately 1,000 hours using an Nvidia V100 GPU (2.12 seconds per image). Examples of the images with
two corresponding heatmaps are shown in Figure S19.
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Fig. S19. We select three exams from the test set and visualize the four standard views from each along with two heatmaps overlaid on the images. For each view, from left to
right, we show: the original image, the image overlaid with a heatmap of the pixel-level prediction for malignancy, the image overlaid with a heatmap of the pixel-level prediction
for benign findings. (a) An exam where the left breast was labeled as malignant as well as benign. (b) An exam in which there is a benign finding in the left breast. (c) An exam
with benign findings in the right breast.
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